Depression is the most commonly treated condition in outpatient mental health settings, and thorough documentation of depression treatment is both clinically and administratively essential. Insurance payers scrutinize depression documentation closely, particularly for extended courses of treatment, and licensing board complaints involving depressed clients with adverse outcomes turn on the quality of the clinical record. Understanding what to document, how to measure it, and how to present treatment progress clearly is fundamental to sustainable depression treatment practice.
PHQ-9 Administration and Documentation
The PHQ-9 (Patient Health Questionnaire-9) is the standard validated measure for depression severity in clinical settings. Scores range from 0-27: 0-4 none/minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Item 9 specifically assesses thoughts of self-harm or suicide, making it both a symptom measure and a risk screening tool.
Administer the PHQ-9 at intake and at regular intervals throughout treatment — ideally every four to six sessions or monthly. Document not just the score but the clinical interpretation and any notable item responses. "PHQ-9 score today: 12 (moderate depression), down from 19 (moderately severe) at intake 8 weeks ago. Item 9 (thoughts of being better off dead or of hurting yourself) remains at 1 (several days), consistent with previous administrations. Client was asked directly about passive ideation; client confirmed these are passing thoughts without intent, plan, or means. No safety plan activation indicated at this time."
This entry demonstrates systematic symptom monitoring, attends to the risk item specifically, and documents the follow-up clinical conversation that item 9 requires when non-zero.
Neurovegetative Symptom Documentation
Depression's neurovegetative symptoms — changes in sleep, appetite, energy, concentration, and psychomotor function — often drive functional impairment and are important treatment outcome indicators. Document these specifically and track them across sessions.
Sleep changes: document sleep onset latency (how long it takes to fall asleep), total sleep duration, early morning awakening, and hypersomnia when present. Appetite and weight: document whether appetite is increased or decreased and any significant weight changes. Energy: document fatigue severity and its functional impact. Concentration: document what activities are impaired by difficulty concentrating (reading, work tasks, conversations). Psychomotor changes: document observed slowing or agitation in session.
"Client reports sleeping 10-12 hours per day, difficulty getting out of bed before noon, and skipping meals frequently due to absent appetite. Energy described as '2 out of 10.' Reports being unable to read more than a paragraph before losing focus, which has made it impossible to complete work assignments this month." This entry documents neurovegetative symptoms specifically enough to support medical necessity and track treatment response.
Functional Impairment Documentation
Medical necessity for depression treatment rests on documented functional impairment — the degree to which depressive symptoms interfere with work, relationships, and self-care. Insurance payers are particularly attentive to functional impairment documentation because it directly links the diagnosis to the need for treatment.
Document functional impact across three domains for every depressed client: occupational or academic (missed work or school, reduced performance, inability to complete tasks, jeopardized position), relational (withdrawal from relationships, conflict secondary to irritability, inability to engage in social activities), and self-care (difficulty with basic hygiene, missed medical appointments, inability to manage household responsibilities). Track these domains across time to demonstrate treatment response.
Distinguishing Depression Diagnoses in Documentation
The depression diagnostic category includes several distinct diagnoses with different clinical implications: Major Depressive Disorder (single episode or recurrent, with or without psychotic features, with or without anxious distress specifier), Persistent Depressive Disorder (formerly dysthymia, chronic low-grade depression), Adjustment Disorder with Depressed Mood, and Bipolar Depression (depressive episode in the context of Bipolar I or II Disorder).
These distinctions matter for documentation because they affect treatment approach, expected course, and medication coordination. Bipolar depression requires particular documentation care — antidepressant monotherapy without a mood stabilizer can precipitate mania in Bipolar I, and the record should reflect awareness of this risk and coordination with the prescribing provider. When a client presents with depression and a history of manic or hypomanic episodes, document the differential and the clinical reasoning supporting the bipolar versus unipolar determination.
Suicidality as a Component of Depression Documentation
Depression is associated with significantly elevated suicide risk, and suicidality assessment must be documented with care at every session where it is relevant. For clients with a known history of suicidal ideation or with current active depression, do not treat suicide risk assessment as a checklist item — document the actual assessment and its basis.
Document: whether suicidal ideation was present (passive or active), ideation frequency and intensity, whether there is a current plan (and if so, what it is), access to means, any intent to act, and protective factors. "Client denied current suicidal ideation. Reports feeling hopeless about the future but is 'too tired to do anything.' Identified protective factors include religious beliefs and concern for impact on her children. PHQ-9 item 9 scored 1 this week. Safety plan reviewed, remains appropriate; emergency contact (husband) confirmed available. No change to level of care warranted."
Medication Coordination Documentation
When a client with depression is also working with a prescribing provider, document the medication coordination in your clinical record. Note when medications are initiated or changed, document the client's reported response (both therapeutic effect and side effects), and document any communication with the prescriber. If a client reports symptoms that may be medication-related (worsening depression, new suicidal ideation following initiation of an antidepressant in the first weeks), document the clinical response including any communication with the prescriber.
Treatment-Resistant Depression Documentation
When a client has not responded to an adequate trial of evidence-based treatment — typically defined as 8-12 sessions of evidence-based therapy with appropriate dose and fidelity, or multiple medication trials — document the pattern explicitly in the clinical record. Describe what has been tried, the duration, and the client's response. Document the clinical reasoning for any treatment modifications: augmentation strategies, referral for psychiatric evaluation, consideration of higher level of care, or referral for specialized assessment (neuropsychological evaluation, TMS evaluation, ECT consultation).
Documentation of treatment-resistant depression is also important for insurance authorization of extended or intensive treatment. Payers who question the continued medical necessity of therapy for a client who has been in treatment for 18 months are more easily answered with a record that clearly traces the treatment history, the partial responses, and the clinical rationale for ongoing care.